Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
Hlavní autoři: | Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D |
---|---|
Médium: | Conference item |
Vydáno: |
2009
|
Podobné jednotky
-
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
Autor: Patmanathan, S.N., a další
Vydáno: (2015) -
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Autor: Anthony, D, a další
Vydáno: (2014) -
The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
Autor: Stradner Martin H, a další
Vydáno: (2011-12-01) -
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
Autor: Siyao Li, a další
Vydáno: (2023-07-01) -
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
Autor: Masayo Aoki, a další
Vydáno: (2020-01-01)